🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share comparison images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and consumer laws, risking fines, legal action or prison.

Platform Reaction and Material Removal

Based on TikTok, the service has removed violative material and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.

Online Marketplace Activities

Research also found groups with up to nine thousand members marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at residence.

After moments of joining one community, a vendor shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, posts display black plastic packages with postal service labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered patients injured by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to potentially significant health risks”.